Background: Early intervention services for psychotic disorders optimally interlock strategies to deliver: (i) Early Detection (ED) to shorten the time between onset of psychotic symptoms and effective treatment (i.e. Duration of Untreated Psychosis, DUP); and (ii) comprehensive intervention during the subsequent 2 to 5 years. In the latter category, are teams ('First-episode Services' or FES) that integrate several empirically supported treatments and adapt their delivery to younger patients and caregivers. There is an urgent need to hasten access to established FES in the U.S. Despite improved outcomes for those in treatment, these FES routinely engage patients a year or more after psychosis onset. The Scandinavian TIPS study was able to effectively reduce DUP in a defined geographic catchment. The guiding questions for this study are: can a U.S. adaptation of the TIPS approach to ED substantially reduce DUP and improve outcomes beyond existing FES?
Methods/design: The primary aim is to determine whether ED can reduce DUP in the US, as compared to usual detection. ED will be implemented by one FES (STEP) based in southern Connecticut, and usual detection efforts will continue at a comparable FES (PREP(R)) serving the greater Boston metropolitan area. The secondary aim is to determine whether DUP reduction can improve presentation, engagement and early outcomes in FES care. A quasi-experimental design will compare the impact of ED on DUP at STEP compared to PREP(R) over 3 successive campaign years. The campaign will deploy 3 components that seek to transform pathways to care in 8 towns surrounding STEP. Social marketing approaches will inform a public education campaign to enable rapid and effective help-seeking behavior. Professional outreach and detailing to a wide variety of care providers, including those in the healthcare, educational and judicial sectors, will facilitate rapid redirection of appropriate patients to STEP. Finally, performance improvement measures within STEP will hasten engagement upon referral.
Discussion: STEP-ED will test an ED campaign adapted to heterogeneous U.S. pathways to care while also improving our understanding of these pathways and their impact on early outcomes.
Trial Registration: ClinicalTrials.gov: NCT02069925 . Registered 20 February 2014.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262386 | PMC |
| http://dx.doi.org/10.1186/s12888-014-0335-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The anomalous effect of COVID-19 pandemic restrictions on the duration of untreated psychosis.
BJPsych Open
December 2024
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA.
Article Synopsis
- The study examined how COVID-19 restrictions influenced the duration of untreated psychosis (DUP) among first-time psychosis patients in Connecticut.
- During the early pandemic, the median DUP significantly dropped from 208 days to 56 days, but later increased to 154 days.
- The time from when psychosis began to starting antipsychotic medication also decreased from 117 days to 35 days, indicating that tighter pandemic restrictions led to quicker treatment responses and could inform future early detection strategies.
Impact of family engagement on client participation in coordinated specialty care for first episodes of psychosis.
BMC Psychiatry
October 2024
Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, 2450 Riverside Avenue, Minneapolis, MN, 55454, USA.
Article Synopsis
- Coordinated specialty care (CSC) programs in the U.S. focus on treating first episodes of psychosis and involve engaging the patient's family in the treatment process, though the effects of this engagement are not well-studied.
- The study compared two groups of clients—those with family engagement and those without—examining their demographics, treatment visits, and self-reported intentions regarding treatment continuity and medication adherence over the first six months.
- Findings indicated that family-engaged clients were generally younger and had different racial demographics; engagement led to more treatment visits and increased intent to attend but did not significantly impact medication adherence. Both groups showed high rates of adherence.
Serine ubiquitination of SQSTM1 regulates NFE2L2-dependent redox homeostasis.
Autophagy
September 2024
Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany.
Article Synopsis
- The KEAP1-NFE2L2 pathway is crucial for how cells respond to metabolic and oxidative stress, regulating the levels of NFE2L2, a key transcription factor that activates protective genes.
- Infection by Legionella pneumophila triggers a process where the autophagy receptor SQSTM1 is modified, preventing its binding to KEAP1, leading to the degradation of NFE2L2 and a drop in antioxidant gene expression during the early phase of infection.
- As the infection progresses, serine ubiquitination levels of SQSTM1 decrease, allowing the activation of NFE2L2-target genes, which differentially affects the host's metabolome and proteome.
Case report: Second report of neuromuscular syndrome caused by biallelic variants in .
Front Genet
September 2024
Beijing Chigene Translational Medical Research Center, Beijing, China.
Introduction: Activating Signal Cointegrator 1 Complex, Subunit 3 () has been implicated in the pathogenesis of neurodevelopmental disorders and neuromuscular diseases (MIM: 620700). This paper analyzes the clinical manifestations of three patients with developmental delay caused by genetic variation. Additionally, we discuss the previously reported clinical features of these patients along with our own findings, thereby enhancing our understanding of these genetic disorders and providing valuable insights into diagnosis, treatment, and potential interventions for affected individuals.
View Article and Find Full Text PDFGlial expression of Drosophila UBE3A causes spontaneous seizures that can be modulated by 5-HT signaling.
Neurobiol Dis
October 2024
Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States of America; Alabama Life Research Institute, University of Alabama, Tuscaloosa, AL, United States of America; Center for Convergent Bioscience and Medicine, University of Alabama, Tuscaloosa, AL, United States of America. Electronic address:
Misexpression of the E3 ubiquitin ligase gene UBE3A is thought to contribute to a range of neurological disorders. In the context of Dup15q syndrome, additional genomic copies of UBE3A give rise to the autism, muscle hypotonia and spontaneous seizures characteristics of the disorder. In a Drosophila model of Dup 15q syndrome, it was recently shown that glial-driven expression of the UBE3A ortholog dube3a led to a "bang-sensitive" phenotype, where mechanical shock triggers convulsions, suggesting glial dube3a expression contributes to hyperexcitability in flies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!